These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 29363047)

  • 21. Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective.
    Pasquali R; Zanotti L; Fanelli F; Mezzullo M; Fazzini A; Morselli Labate AM; Repaci A; Ribichini D; Gambineri A
    J Clin Endocrinol Metab; 2016 May; 101(5):2013-22. PubMed ID: 26964728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.
    Azziz R; Carmina E; Dewailly D; Diamanti-Kandarakis E; Escobar-Morreale HF; Futterweit W; Janssen OE; Legro RS; Norman RJ; Taylor AE; Witchel SF;
    Fertil Steril; 2009 Feb; 91(2):456-88. PubMed ID: 18950759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PCOS in adolescents.
    Diamanti-Kandarakis E
    Best Pract Res Clin Obstet Gynaecol; 2010 Apr; 24(2):173-83. PubMed ID: 19932060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity and the polycystic ovary syndrome.
    Gambineri A; Pelusi C; Vicennati V; Pagotto U; Pasquali R
    Int J Obes Relat Metab Disord; 2002 Jul; 26(7):883-96. PubMed ID: 12080440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgen excess disorders in women: the severe insulin-resistant hyperandrogenic syndrome, HAIR-AN.
    Rager KM; Omar HA
    ScientificWorldJournal; 2006 Jan; 6():116-21. PubMed ID: 16435040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How polycystic ovary syndrome came into its own.
    Azziz R
    F S Sci; 2021 Feb; 2(1):2-10. PubMed ID: 35559761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current approaches to the diagnosis and treatment of polycystic ovarian syndrome in youth.
    Harwood K; Vuguin P; DiMartino-Nardi J
    Horm Res; 2007; 68(5):209-17. PubMed ID: 17426408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PCOS in adolescence and type 2 diabetes.
    Carreau AM; Baillargeon JP
    Curr Diab Rep; 2015 Jan; 15(1):564. PubMed ID: 25398203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Polycystic ovary syndrome: PCOS].
    Kitaoka Y
    Nihon Rinsho; 1997 Nov; 55(11):3012-9. PubMed ID: 9396305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polycystic ovary syndrome: clinical perspectives and management.
    Futterweit W
    Obstet Gynecol Surv; 1999 Jun; 54(6):403-13. PubMed ID: 10358853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What every physician should know about polycystic ovary syndrome.
    Rosenfield RL
    Dermatol Ther; 2008; 21(5):354-61. PubMed ID: 18844713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polycystic Ovary Syndrome: Common Questions and Answers.
    Williams T; Moore JB; Regehr J
    Am Fam Physician; 2023 Mar; 107(3):264-272. PubMed ID: 36920819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence.
    Ibáñez L; Oberfield SE; Witchel S; Auchus RJ; Chang RJ; Codner E; Dabadghao P; Darendeliler F; Elbarbary NS; Gambineri A; Garcia Rudaz C; Hoeger KM; López-Bermejo A; Ong K; Peña AS; Reinehr T; Santoro N; Tena-Sempere M; Tao R; Yildiz BO; Alkhayyat H; Deeb A; Joel D; Horikawa R; de Zegher F; Lee PA
    Horm Res Paediatr; 2017; 88(6):371-395. PubMed ID: 29156452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Body mass index and ovarian function are associated with endocrine and metabolic abnormalities in women with hyperandrogenic syndrome.
    Cupisti S; Kajaia N; Dittrich R; Duezenli H; W Beckmann M; Mueller A
    Eur J Endocrinol; 2008 May; 158(5):711-9. PubMed ID: 18426831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association.
    Morgante G; Cappelli V; Di Sabatino A; Massaro MG; De Leo V
    Minerva Ginecol; 2015 Oct; 67(5):457-63. PubMed ID: 26491824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The diagnosis of polycystic ovary syndrome in adolescents.
    Carmina E; Oberfield SE; Lobo RA
    Am J Obstet Gynecol; 2010 Sep; 203(3):201.e1-5. PubMed ID: 20435290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MANAGEMENT OF ENDOCRINE DISEASE: Secondary polycystic ovary syndrome: theoretical and practical aspects.
    Pasquali R; Diamanti-Kandarakis E; Gambineri A
    Eur J Endocrinol; 2016 Oct; 175(4):R157-69. PubMed ID: 27170519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polycystic ovary syndrome.
    Norman RJ; Dewailly D; Legro RS; Hickey TE
    Lancet; 2007 Aug; 370(9588):685-97. PubMed ID: 17720020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimal management of polycystic ovary syndrome in adolescence.
    Hecht Baldauff N; Arslanian S
    Arch Dis Child; 2015 Nov; 100(11):1076-83. PubMed ID: 26101431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
    Jeanes YM; Reeves S
    Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.